Lhasa Limited

Have you seen our latest announcement? Mirabilis 4.4.2 is out, boosting decision-making speed in drug development. Roberta Drekener & Amber Carr explain the highlights in a video. Get in touch to start your free trial: buff.ly/4HzAEtj

2025 was a significant year for Lhasa. Our end-of-year video reflects on the key milestones and shared achievements that shaped the year. 🎥 To explore these developments in more detail, read our 2025 wrap-up blog: buff.ly/jqAnwlU

We'll be attending the 35th GUM Meeting in Ludwigshafen, Germany! Lhasa Principal Scientist David Ponting will present a poster on innovation in carcinogenicity assessments, specifically how we support confidence in carcinogenic data. Learn more: buff.ly/ihvLU2G

Catch our talk at 13th Exhibition and Congress for Pharmaceutical, Biotechnological and Veterinary Science and Technology: “Chemical Safety in Manufacturing Processes: Are We Sure About Safety?”. 📅 19 September | 16:10 – 17:00 📍 Hall 3 👉 buff.ly/IArnurQ

We've been shortlisted for the Best Tech Place to Work Award by Leeds Digital Festival Awards! 🎉Being shortlisted is an incredible achievement, and it’s a reflection of the environment we’ve created together here at Lhasa, through collaboration and innovation!!

Catch Lhasa Principal Scientist Susanne Stalford at EUROTOX 2025 as she co-chairs a session exploring the evolving landscape of carcinogenicity testing. 📅 Monday 15 September | 10:00 – 12:00 🔗 buff.ly/pcR5ZIx

The release of the new ICH Q3E draft guideline marks a significant step toward a globally harmonised approach for Extractable and Leachable (E&L) assessments. In our latest blog, our scientists break down the key takeaways from this anticipated guideline: buff.ly/AyILHAc

Get up to speed with the ICH Q3D guidelines in our upcoming webinar, where expert speakers will equip you with the tools to take effective steps toward building a robust control strategy. 📅 16th September 🕕 10am-11:30am BST | 11:00-1:30pm CEST 👉 buff.ly/72YREJU

Ready to master ICH M7 risk assessments? Join us for our Spanish-language webinar, where we’ll explore how in silico solutions can help address stability challenges in drug development. 📅 5th August 🕕 09:00 (CST) | 10:00 (COT) | 12:00 (ART) 👉 buff.ly/s33KxtT

Are you ready for #EUROTOX2025? It's just one month away, and we're excited to be delivering a range of expert-led sessions and presentations! 👋 Come meet our team at booth A61. Find out more about our sessions and booth location: buff.ly/HUOnsq0

📣Join us the Lhasa 2025 Hyderabad Symposium! You'll gain the essential knowledge and practical tools you need to ✅ Navigate regulatory changes ✅ Stay ahead of global trends ✅ Strengthen risk assessment strategies ✅ Address nitrosamine challenges 🔗 buff.ly/JGAwYwl

You may have heard the news... We were recently named the Workplace Culture Champion at the Prolific North Awards 2025! Read our latest blog post to discover what drives our award-winning culture and how we're building a place where everyone can thrive: buff.ly/LUFto8U

Are you an early-career scientist in the UK working in Computational Toxicology or Genotoxicity? We’d love to see your work, apply now for the Lhasa Young UK Scientists Award 2025! 👉 buff.ly/O3cCZhW Entries close on the 31st October.

We're excited to see a brand-new paper released from the HESI Nitrosamine Research Programme! Read the publication to learn how the Lhasa Carcinogenicity Database helped address a key unresolved question in the #nitrosamines crisis: buff.ly/QZQHPfM

📣 Calling all Spanish speakers. Join us for our webinar, where we’ll explore how in silico solutions can help address stability challenges in drug development. 📅 5th August 🕕 09:00 (CST) | 10:00 (COT) | 12:00 (ART) Don't miss out. Register now! buff.ly/s33KxtT

Join us for our upcoming webinar, where we’ll explore how in silico solutions can help address stability challenges in drug development. 📅 5th August 🕕 09:00 (CST) | 10:00 (COT) | 12:00 (ART) Don't miss out. Register now! buff.ly/s33KxtT

In our recent webinar, experts from BfR, Syngenta, and Lhasa came together to explore how in silico tools are being used to support #genotoxicity assessments. For those who couldn’t join the live session, here’s a summary: buff.ly/AKgCNdf

We’ve just released the latest versions of Derek Nexus (6.4.2) and Sarah Nexus (5.0.0), featuring updates to help scientists make confident, transparent, evidence-based safety assessments. 📣 For the full details of the release, read our news article: bit.ly/4k7XdRe

Missed out on #ScienceOfStability2025? No problem! We've summarized the key insights on drug stability & innovation in our new blog post. Read now: buff.ly/ugEgx2C